Advertisement
Screener

ELEVANCE HEALTH, INC. (ELV) Restructuring and Related Cost, Incurred Cost

2.8 / 5 stars · 68/120 Roast Me

ELEVANCE HEALTH, INC. Restructuring and Related Cost, Incurred Cost

ELEVANCE HEALTH, INC. (ELV) reported Restructuring and Related Cost, Incurred Cost of $730.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-10-18.

Discontinued › Expense Statement › Operating Expenses

us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2023-10-18

  • ELEVANCE HEALTH, INC. restructuring and related cost, incurred cost for the quarter ending 2023-09-30 was $730.00M.
  • ELEVANCE HEALTH, INC. restructuring and related cost, incurred cost for the quarter ending 2020-09-30 was $607.00M.
Period endRestructuring and Related Cost, Incurred Cost 3 monthRestructuring and Related Cost, Incurred Cost 12 month
2023-09-30$730.00M
10-Q · filed 2023-10-18
2022-12-31$39.00M
10-Q · filed 2023-10-18
2021-12-31$202.00M
10-Q · filed 2023-10-18
2020-12-31$653.00M
10-Q · filed 2023-10-18
2020-09-30$607.00M
10-Q · filed 2020-10-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cigna Group (CI)United States$70.160B10.44
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62